Drug intelligence / Profile preview

antimycin

Development stage
Preclinical
Modality
Small Molecules
Administration
Intraperitoneal, Parenteral
01

Overview

Antimycin is a group of secondary metabolites produced by *Streptomyces* bacteria, with Antimycin A being the most prominent and widely studied member. It is a potent inhibitor of the mitochondrial electron transport chain, specifically targeting the **cytochrome bc1 complex (Complex III)**. By binding to the Qi site of the complex, antimycin blocks the transfer of electrons from cytochrome b to ubiquinone, effectively halting cellular respiration and ATP production. Due to its high toxicity, it is primarily utilized as a **research reagent** to study mitochondrial bioenergetics and as a **piscicide** (fish poison) in aquaculture to manage fish populations. In oncology research, antimycin is used to probe the metabolic vulnerabilities of cancer cells, such as acute myeloid leukemia (AML), which may exhibit reduced respiratory reserve capacity and heightened sensitivity to mitochondrial inhibition.

Brand names
Fintrol
Other names
Antimycin AAntimycin A1Antimycin A2Antimycin A3Antimycin A4
02

Targets

Cytochrome bc1 complex cytochrome b Qi siteUbiquinol-cytochrome c oxidoreductase (Complex III)cytochrome b6f (Cytochrome b6-f complex)bc1 complex (Cytochrome bc1 complex (plasmodium))

Beyond the preview

Go deeper on antimycin.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on antimycin.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call